These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11943729)

  • 41. Molecular control of the cell cycle in cancer: biological and clinical aspects.
    Møller MB
    Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma.
    Seki R; Okamura T; Koga H; Yakushiji K; Hashiguchi M; Yoshimoto K; Ogata H; Imamura R; Nakashima Y; Kage M; Ueno T; Sata M
    Am J Hematol; 2003 Aug; 73(4):230-5. PubMed ID: 12879424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.
    Møller MB; Nielsen O; Pedersen NT
    Am J Clin Pathol; 2001 Mar; 115(3):404-12. PubMed ID: 11242797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.
    Zhu XH; Nguyen H; Halicka HD; Traganos F; Koff A
    Mol Cell Biol; 2004 Jul; 24(13):6058-66. PubMed ID: 15199159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of beta 1-integrin-mediated hepatoma cell growth involves p27 and S-phase kinase-associated protein 2.
    Zhang H; Ozaki I; Mizuta T; Yoshimura T; Matsuhashi S; Hisatomi A; Tadano J; Sakai T; Yamamoto K
    Hepatology; 2003 Aug; 38(2):305-13. PubMed ID: 12883474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium.
    Lahav-Baratz S; Ben-Izhak O; Sabo E; Ben-Eliezer S; Lavie O; Ishai D; Ciechanover A; Dirnfeld M
    Mol Hum Reprod; 2004 Aug; 10(8):567-72. PubMed ID: 15220466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY; Ding W; Xie LP; Chen ZD
    Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p27 Kip1 protein expression in Hashimoto's thyroiditis.
    Troncone G; Iaccarino A; Caleo A; Bifano D; Pettinato G; Palombini L
    J Clin Pathol; 2003 Aug; 56(8):587-91. PubMed ID: 12890807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
    Signoretti S; Di Marcotullio L; Richardson A; Ramaswamy S; Isaac B; Rue M; Monti F; Loda M; Pagano M
    J Clin Invest; 2002 Sep; 110(5):633-41. PubMed ID: 12208864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
    Bhatt KV; Hu R; Spofford LS; Aplin AE
    Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications.
    Erlanson M; Portin C; Linderholm B; Lindh J; Roos G; Landberg G
    Blood; 1998 Aug; 92(3):770-7. PubMed ID: 9680343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of the F-box protein Skp2 in lymphomagenesis.
    Latres E; Chiarle R; Schulman BA; Pavletich NP; Pellicer A; Inghirami G; Pagano M
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2515-20. PubMed ID: 11226270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
    Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
    Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
    Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
    Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
    Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
    Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase.
    Xu K; Belunis C; Chu W; Weber D; Podlaski F; Huang KS; Reed SI; Vassilev LT
    Biochem J; 2003 May; 371(Pt 3):957-64. PubMed ID: 12529174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).
    Zhang YW; Nakayama K; Nakayama K; Morita I
    Cancer Res; 2003 Apr; 63(7):1623-30. PubMed ID: 12670914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
    Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
    Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
    Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
    Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.